The contribution of the endogenous TRPV1 ligands 9-HODE and 13-HODE to nociceptive processing and their role in peripheral inflammatory pain mechanisms

British Journal of Pharmacology

Volumn 168, Issue 8, 2013, Pages 1961-1974

  Alsalem, Mohammad ^a   Wong, Amy ^a   Millns, Paul ^a   Arya, Pallavi Huma ^a   Chan, Michael Siang Liang ^a   Bennett, Andrew ^a   Barrett, David A ^a   Chapman, Victoria ^a   Kendall, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

15 lipoxygenase; dorsal root ganglion; HODE; inflammatory pain; TRPV1

Indexed keywords

13 HYDROXYOCTADECADIENOIC ACID; 13 HYDROXYOCTADECADIENOIC ACID ANTIBODY; 9 HYDROXYOCTADECADIENOIC ACID; 9 HYDROXYOCTADECADIENOIC ACID ANTIBODY; ANALGESIC AGENT; ARACHIDONATE 15 LIPOXYGENASE; CALCIUM; LIGAND; LINOLEIC ACID; PD 146176; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; 13-HYDROXY-9,11-OCTADECADIENOIC ACID; 6,11-DIHYDRO-5-THIA-11-AZA-BENZO(A)-FLUORENE; 9-HYDROXY-10,12-OCTADECADIENOIC ACID; CONJUGATED LINOLEIC ACID; FLUORENE DERIVATIVE; TRPV1 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; EVOKED RESPONSE; HYPERALGESIA; INFLAMMATORY PAIN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MALE; NOCICEPTION; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL INFLAMMATORY PAIN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SPINAL GANGLION; ANIMAL; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; INFLAMMATION; METABOLISM; MOUSE; PAIN; SPRAGUE DAWLEY RAT;

ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; DISEASE MODELS, ANIMAL; FLUORENES; GANGLIA, SPINAL; INFLAMMATION; LINOLEIC ACIDS; LINOLEIC ACIDS, CONJUGATED; MALE; MICE; PAIN; RATS, SPRAGUE-DAWLEY; TRPV CATION CHANNELS;

EID: 84875437380     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12092     Document Type: Article

References (37)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edn. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Baer AN, Costello PB, Green FA, (1991). In vivo activation of an omega-6 oxygenase in human skin. Biochem Biophys Res Commun 180: 98-104.
3. Buczynski MW, Svensson CI, Dumlao DS, Fitzsimmons BL, Shim JH, Scherbart TJ, et al. (2010). Inflammatory hyperalgesia induces essential bioactive lipid production in the spinal cord. J Neurochem 114: 981-993.
4. Caterina M, Schumacher M, Tominaga M, Rosen T, Levine J, Juluis D, (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
5. Caterina MJ, Julius D, (2001). The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 24: 487-517.
6. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, et al. (2000). Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313.
7. Chu KL, Chandran P, Joshi SK, Jarvis MF, Kym PR, McGaraughty S, (2010). TRPV1-related modulation of spinal neuronal activity and behavior in a rat model of osteoarthritic pain. Brain Res 1369: 158-166.
8. Clayton N, Marshall FH, Bountra C, O'Shaughnessy CT, (2002). CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 96: 253-260.
9. Daret D, Blin P, Larrue J, (1989). Synthesis of hydroxy fatty acids from linoleic acid by human blood platelets. Prostaglandins 38: 203-214.
10. De Petrocellis L, Schiano Moriello A, Imperatore R, Cristino L, Starowicz K, Di Marzo V, (2012). A re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neurons. Br J Pharmacol 167: 1643-1651.
11. Flores CM, Vasko MR, (2010). The deorphanization of TRPV1 and the emergence of octadecadienoids as a new class of lipid transmitters. Mol Interv 10: 137-140.
12. Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, et al. (2005). AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 313: 474-484.
13. Gregus AM, Doolen S, Dumlao DS, Buczynski MW, Takasusuki T, Fitzsimmons BL, et al. (2012). Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc Natl Acad Sci 109: 6721-6726.
14. Gunthorpe MJ, Szallasi A, (2008). Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr Pharm Des 14: 32-41.
15. Herlin T, Fogh K, Ewald H, Hansen ES, Knudsen VE, Holm I, et al. (1988). Changes in lipoxygenase products from synovial fluid in carrageenan induced arthritis in dogs. APMIS 96: 601-604.
16. Huang J, Zhang X, McNaughton PA, (2006). Inflammatory pain: the cellular basis of heat hyperalgesia. Curr Neuropharmacol 4: 197-206.
17. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, et al. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A 99: 8400-8405.
18. Hwang SW, Cho H, Kwak J, Lee S-Y, Kang C-J, Jung J, et al. (2000). Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A 97: 6155-6160.
19. Jhaveri MD, Richardson D, Robinson I, Garle MJ, Patel A, Sun Y, et al. (2008). Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. Neuropharmacology 55: 85-93.
20. Krarup AL, Ny L, Astrand M, Bajor A, Hvid-Jensen F, Hansen MB, et al. (2011). Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Aliment Pharmacol Ther 33: 1113-1122.
21. Lindsay RM, (1988). Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci 8: 2394-2405.
22. McGaraughty S, Chu KL, Brown BS, Zhu CZ, Zhong C, Joshi SK, et al. (2008). Contributions of central and peripheral TRPV1 receptors to mechanically evoked and spontaneous firing of spinal neurons in inflamed rats. J Neurophysiol 100: 3158-3166.
23. Millns PJ, Chapman V, Kendall DA, (2001). Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. Br J Pharmacol 132: 969-971.
24. Patwardhan AM, Scotland PE, Akopian AN, Hargreaves KM, (2009). Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc Natl Acad Sci U S A 106: 18820-18824.
25. Patwardhan AM, Akopian AN, Ruparel NB, Diogenes A, Weintraub ST, Uhlson C, et al. (2010). Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents. J Clin Invest 120: 1617-1626.
26. Puttfarcken PS, Han P, Joshi SK, Neelands TR, Gauvin DM, et al. (2010). A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3, 4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model. Pain 150: 319-326.
27. Round P, Priestley A, Robinson J, (2011). An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subjects. Br J Clin Pharmacol 72: 921-931.
28. Sendobry SM, Cornicelli JA, Welch K, Bocan T, Tait B, Trivedi BK, et al. (1997). Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol 120: 1199-1206.
29. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, et al. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129: 227-230.
30. Starowicz K, Nigam S, Di Marzo V, (2007). Biochemistry and pharmacology of endovanilloids. Pharmacol Ther 114: 13-33.
31. Szallasi A, Cortright DN, Blum CA, Eid SR, (2007). The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 6: 357-372.
32. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, et al. (1998). The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21: 531-543.
33. Tõth A, Boczán J, Kedei N, Lizanecz E, Bagi Z, Papp Z, et al. (2005). Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Molecular Brain Research 135: 162-168.
34. Willis W, (2009). The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli. Exp Brain Res 196: 5-11.
35. Yoshida Y, Niki E, (2006). Bio-markers of lipid peroxidation in vivo: hydroxyoctadecadienoic acid and hydroxycholesterol. Biofactors 27: 195-202.
36. Zhang J-H, Pearson T, Matharoo-Ball B, Ortori CA, Warren AY, Khan R, et al. (2007). Quantitative profiling of epoxyeicosatrienoic, hydroxyeicosatetraenoic, and dihydroxyeicosatetraenoic acids in human intrauterine tissues using liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem 365: 40-51.
37. Ziboh VA, Miller CC, Cho Y, (2000). Significance of lipoxygenase-derived monohydroxy fatty acids in cutaneous biology. Prostaglandins Other Lipid Mediat 63: 3-13.